  Using personal generated health data (PGHD) during medical consultations can
be beneficial for both patients and clinicians. However, multiple acceptance
barriers such as lack of PGHD reliability prevents a routine usage of this
data. A clinical decision support system, called FullFlow, has been developed
to address these acceptance barriers. The objective of this study was to
determine if FullFlow was useful during consultations and to verify the
hypothesis that the higher PGHD reliability, the more effective the system is.
The assessment relied on a medical pilot during which clinicians and patients
with diabetes used the FullFlow during medical consultations. The data
collection relied on a post-consultation questionnaire in addition to system
logs. This study showed that the PGHD reliability was low for an overwhelming
majority of consultations. The information displayed was useful in half of the
consultations according to the clinicians who answered the questionnaire.
Despite this, the overwhelming majority of clinicians who answered the
questionnaire found that the designed FullFlow system permitted to gain
insights of the situation of the patients. The study showed the higher the PGHD
reliability is, the more useful the system is for clinicians. PGHD usage in
clinical settings can permit clinicians to gain valuable information regarding
the situations of their patients. A clinical decision system can present useful
information to clinicians. While the PGHD reliability is correlated to the
usefulness of such system, it is not the only factor impacting it: context of
the clinicians and patients such as novelty of usage and personal goals also
plays a role in determining on how such system is useful for clinicians.
However, due to a limited number of participants, a new medical pilot must be
performed in order to confirm the results of this study.
